{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:37:26Z","timestamp":1768678646493,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":1023,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.joca.2011.02.020","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T19:42:08Z","timestamp":1300304528000},"page":"483-492","source":"Crossref","is-referenced-by-count":45,"title":["Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT database"],"prefix":"10.1016","volume":"19","author":[{"given":"R.H.","family":"Dworkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Peirce-Sandner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.C.","family":"Turk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gibofsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.S.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.P.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2011.02.020_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpain.2006.02.013","article-title":"Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials","volume":"11","author":"Bjordal","year":"2007","journal-title":"Eur J Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib3","unstructured":"U.S. Department of Health and Human Services. Guidance for industry: E10 choice of control group and related issues in clinical trials, 2001; Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm073139.pdf."},{"key":"10.1016\/j.joca.2011.02.020_bib4","unstructured":"U.S. Department of Health and Human Services. Guidance for industry: clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA), 1999; Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm071579.pdf."},{"key":"10.1016\/j.joca.2011.02.020_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","article-title":"OMERACT\u2013OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited","volume":"12","author":"Pham","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib6","unstructured":"European Medicines Agency. Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis, 2009; Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003443.pdf."},{"key":"10.1016\/j.joca.2011.02.020_bib7","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl","key":"10.1016\/j.joca.2011.02.020_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009748709102182","article-title":"Indexes of severity for osteoarthritis of the hip and knee: validation: value in comparison with other assessment tests","volume":"65","author":"Lequesne","year":"1987","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.joca.2011.02.020_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1063-4584(05)80101-3","article-title":"Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society","volume":"4","author":"Altman","year":"1996","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib10","first-page":"799","article-title":"Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III","volume":"24","author":"Bellamy","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2011.02.020_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/joca.2000.0361","article-title":"Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative","volume":"8","author":"Dougados","year":"2000","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.joca.2006.02.010","article-title":"Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International","volume":"14","author":"Maheu","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","article-title":"Core outcome domains for chronic pain clinical trials: IMMPACT recommendations","volume":"106","author":"Turk","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pain.2006.09.028","article-title":"Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations","volume":"125","author":"Turk","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib16","first-page":"105","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.08.019","article-title":"Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations","volume":"146","author":"Dworkin","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pain.2010.02.002","article-title":"Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database","volume":"150","author":"Dworkin","year":"2010","journal-title":"Pain"},{"issue":"Suppl","key":"10.1016\/j.joca.2011.02.020_bib19","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.pain.2010.11.008","article-title":"Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION","volume":"152","author":"Dworkin","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib20","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/ard.2008.092015","article-title":"The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials","volume":"67","author":"Zhang","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2011.02.020_bib21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.joca.2010.04.005","article-title":"Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled trials","volume":"18","author":"Trijau","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib22","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.2, 2009; Available at: http:\/\/www.mrc-bsu.cam.ac.uk\/cochrane\/handbook."},{"key":"10.1016\/j.joca.2011.02.020_bib23","series-title":"Osteoarthritis: National Clinical Guideline for Care and Management in Adults","author":"National Collaborating Centre for Chronic Conditions","year":"2008"},{"key":"10.1016\/j.joca.2011.02.020_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2011.02.020_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/joca.2002.0533","article-title":"Algo-functional assessment of knee osteoarthritis: comparison of the test-retest reliability and construct validity of the WOMAC and Lequesne indexes","volume":"10","author":"Faucher","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P","article-title":"Meta-analysis: formulating, evaluating, combining, and reporting","volume":"18","author":"Normand","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.joca.2011.02.020_bib28","series-title":"Meta-analysis of Controlled Clinical Trials","author":"Whitehead","year":"2002"},{"key":"10.1016\/j.joca.2011.02.020_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1529-0131(200010)13:5<280::AID-ANR6>3.0.CO;2-6","article-title":"Comparison of the responsiveness of symptomatic outcome measures in knee osteoarthritis","volume":"13","author":"Gentelle-Bonnassies","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.joca.2011.02.020_bib30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/MLR.0b013e3181eaf835","article-title":"Comparative responsiveness of pain outcome measures among primary care patients with musculoskeletal pain","volume":"48","author":"Krebs","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.joca.2011.02.020_bib31","first-page":"2473","article-title":"WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire","volume":"29","author":"Bellamy","year":"2002","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2011.02.020_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.joca.2003.11.006","article-title":"Relative efficiency and validity properties of a visual analogue vs a categorical scaled version of the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index: Spanish versions","volume":"12","author":"Villanueva","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1185\/03007999909113371","article-title":"Comparative study of self-rating pain scales in osteoarthritis patients","volume":"15","author":"Bellamy","year":"1999","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.joca.2011.02.020_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1063-4584(03)00082-7","article-title":"Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement","volume":"11","author":"Bolognese","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2288-5-31","article-title":"Lack of interchangeability between visual analogue and verbal rating pain scales: a cross sectional description of pain etiology groups","volume":"5","author":"Lund","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.joca.2011.02.020_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpain.2010.07.009","article-title":"Treatment satisfaction in osteoarthritis and low back pain: the role of pain, physical and emotional functioning, sleep, and adverse events","volume":"12","author":"Dworkin","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.joca.2008.04.009","article-title":"Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis","volume":"16","author":"Bingham","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2011.02.020_bib38","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3899\/jrheum.080077","article-title":"Systematic review of discriminating power of outcome measures used in clinical trials of fibromyalgia","volume":"35","author":"Carville","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2011.02.020_bib39","first-page":"2683","article-title":"Responsiveness of fibromyalgia clinical trial outcome measures","volume":"27","author":"Dunkl","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2011.02.020_bib40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0003-4967(24)43382-7","article-title":"Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention","volume":"60","author":"Angst","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2011.02.020_bib41","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.arth.2006.10.006","article-title":"Comparison of the responsiveness of the SF-36 and WOMAC in patients undergoing total hip arthroplasty","volume":"22","author":"Soohoo","year":"2007","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.joca.2011.02.020_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.pain.2008.06.024","article-title":"Placebo response in neuropathic pain trials","volume":"138","author":"Quessy","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib43","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1212\/WNL.65.12_suppl_4.S32","article-title":"Methodological issues in clinical trials of opioids for chronic pain","volume":"65","author":"Katz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.joca.2011.02.020_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.wnl.0000275528.01263.6c","article-title":"Clinical trial outcome in neuropathic pain: relationship to study characteristics","volume":"70","author":"Katz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.joca.2011.02.020_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4675","article-title":"Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis","volume":"341","author":"Wandel","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2011.02.020_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c6328","article-title":"Effect size is encouraging","volume":"341","author":"Pelletier","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2011.02.020_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pain.2008.10.026","article-title":"The impact of selective publication on clinical research in pain","volume":"140","author":"Rowbotham","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2009.09.026","article-title":"The case for publishing \u2018negative\u2019 trials","volume":"146","author":"Rowbotham","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib49","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/1529-0131(200107)44:7<1599::AID-ART283>3.0.CO;2-N","article-title":"Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis","volume":"44","author":"Scott-Lennox","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2011.02.020_bib50","first-page":"522","article-title":"Comparison of pain measures among patients with osteoarthritis","volume":"11","author":"Allen","year":"2010","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.joca.2011.02.020_bib51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jclinepi.2010.03.013","article-title":"Osteoarthritis Index delivered by mobile phone (m-WOMAC) is valid, reliable, and responsive","volume":"64","author":"Bellamy","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.joca.2011.02.020_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard.2004.022905","article-title":"Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement","volume":"64","author":"Tubach","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2011.02.020_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/ar2118","article-title":"Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomized, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis","volume":"9","author":"Dougados","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2011.02.020_bib54","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jclinepi.2009.07.011","article-title":"BLISS index using WOMAC index detects between-group differences at low-intensity symptom states in osteoarthritis","volume":"63","author":"Bellamy","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.joca.2011.02.020_bib55","unstructured":"U.S. Department of Health and Human Services. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims, 2009; Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf."},{"key":"10.1016\/j.joca.2011.02.020_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/qshc.8.1.22","article-title":"Patient centred assessment of quality of life for patients with four common conditions","volume":"8","author":"Ruta","year":"1999","journal-title":"Qual Health Care"},{"key":"10.1016\/j.joca.2011.02.020_bib57","first-page":"445","article-title":"Individualized functional priority approach to the assessment of health related quality of life in rheumatology","volume":"28","author":"Clinch","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2011.02.020_bib58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jclinepi.2005.01.012","article-title":"A\u00a0study compared nine patient-specific indices for musculoskeletal disorders","volume":"58","author":"Jolles","year":"2005","journal-title":"J\u00a0Clin Epidemiol"}],"updated-by":[{"DOI":"10.1016\/j.joca.2011.05.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000}}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458411000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458411000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:37:14Z","timestamp":1741102634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458411000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1063458411000781"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2011.02.020","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}